Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion type Assertion NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_head.
- NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion description "[Thus, our report reveals for the first time that sequential treatment of Aurora B inhibitors and cisplatin is essential to inhibit ovarian carcinoma by inducing polyploidy and downregulating c-Myc and that c-Myc is identified as a predictive biomarker to select cells responsive to chemotherapeutical combinations targeting Aurora B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_provenance.
- NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion evidence source_evidence_literature NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_provenance.
- NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion SIO_000772 25411027 NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_provenance.
- NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion wasDerivedFrom befree-2016 NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_provenance.
- NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_assertion wasGeneratedBy ECO_0000203 NP1238746.RAvmhsHsg223DxLDWZRAYpxeH9_ov97DkALWM3QCn2otI130_provenance.